Ad is loading...
MFVZX
Price
$19.40
Change
-$0.10 (-0.51%)
Updated
Nov 15 closing price
RWMEX
Price
$63.76
Change
-$0.73 (-1.13%)
Updated
Nov 15 closing price
Ad is loading...

MFVZX vs RWMEX

Header iconMFVZX vs RWMEX Comparison
Open Charts MFVZX vs RWMEXBanner chart's image
MassMutual Equity Opports I
Price$19.40
Change-$0.10 (-0.51%)
VolumeN/A
CapitalizationN/A
American Funds Washington Mutual R4
Price$63.76
Change-$0.73 (-1.13%)
VolumeN/A
CapitalizationN/A
MFVZX vs RWMEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFVZX vs. RWMEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFVZX is a Buy and RWMEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWMEX has more cash in the bank: 191B vs. MFVZX (613M). RWMEX pays higher dividends than MFVZX: RWMEX (1.45) vs MFVZX (1.22). MFVZX was incepted earlier than RWMEX: MFVZX (14 years) vs RWMEX (23 years). RWMEX is a more actively managed with annual turnover of: 30.00 vs. MFVZX (24.00). MFVZX has a lower initial minimum investment than RWMEX: MFVZX (0) vs RWMEX (250). RWMEX annual gain was more profitable for investors over the last year : 18.03 vs. MFVZX (15.48). RWMEX return over 5 years is better than : 37.76 vs. MFVZX (10.59).
MFVZXRWMEXMFVZX / RWMEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD13.12013.37798%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets613M191B0%
Annual Yield % from dividends1.221.4584%
Returns for 1 year15.4818.0386%
Returns for 3 years-6.5610.11-65%
Returns for 5 years10.5937.7628%
Returns for 10 years-10.3756.39-18%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LWAY23.561.17
+5.23%
Lifeway Foods
NOAH11.720.31
+2.72%
Noah Holdings Limited
PEG88.991.99
+2.29%
Public Service Enterprise Group
ANTX1.00N/A
N/A
AN2 Therapeutics
DNB12.12-0.18
-1.46%
Dun & Bradstreet Holdings